Elevance Health, Inc. (ELV) fundamentals from SEC filings — revenue $199.1B, net margin 2.8%, diluted EPS $25.21 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B |
| Net income | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B |
| Net margin | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |
| Diluted EPS | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| Free cash flow | $7.3B | $7.2B | $6.8B | $4.6B | $3.2B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home